financetom
Business
financetom
/
Business
/
--Roper Technologies Keeps Dividend at $0.75 per Share, Payable Oct. 21 to Shareholders of Record on Oct. 8
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Roper Technologies Keeps Dividend at $0.75 per Share, Payable Oct. 21 to Shareholders of Record on Oct. 8
Sep 19, 2024 1:31 AM

12:08 PM EDT, 09/18/2024 (MT Newswires) --

Price: 548.65, Change: -3.19, Percent Change: -0.58

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US auto sales set to rise in August on Labor Day weekend surge, report shows
US auto sales set to rise in August on Labor Day weekend surge, report shows
Aug 29, 2024
Aug 29 (Reuters) - New vehicle sales in the United States are projected to rise over 4% in August from a year ago, partly boosted by the Labor Day weekend falling within the reporting period, according to a joint report by industry consultants J.D. Power and GlobalData ( GLDAF ) on Thursday. On a seasonally adjusted annualized rate (SAAR) basis,...
OpenAI, Anthropic sign deals with US govt for AI research and testing
OpenAI, Anthropic sign deals with US govt for AI research and testing
Aug 29, 2024
Aug 29 (Reuters) - AI startups OpenAI and Anthropic have signed deals with the United States government for research, testing and evaluation of their artificial intelligence models, the U.S. Artificial Intelligence Safety Institute said on Thursday. The first-of-their-kind agreements come at a time when the companies are facing regulatory scrutiny over safe and ethical use of AI technologies. California legislators...
Brown-Forman Fiscal Q1 Earnings, Net Sales Fall
Brown-Forman Fiscal Q1 Earnings, Net Sales Fall
Aug 29, 2024
08:33 AM EDT, 08/29/2024 (MT Newswires) -- Brown-Forman (BF.A, BF.B) reported fiscal Q1 earnings Thursday of $0.41 per diluted share, down from $0.48 a year earlier. Analysts polled by Capital IQ expected $0.46. Net sales for the fiscal quarter ended July 31 was $951 million, down from $1.04 billion a year earlier. Analysts surveyed by Capital IQ expected $990.8 million....
Johnson & Johnson Submits BLA to FDA for Nipocalimab Approval As Treatment of Chronic Neuromuscular Disease
Johnson & Johnson Submits BLA to FDA for Nipocalimab Approval As Treatment of Chronic Neuromuscular Disease
Aug 29, 2024
08:47 AM EDT, 08/29/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Thursday it has submitted a Biologics License Application to the US Food and Drug Administration for the approval of nipocalimab to treat generalized myasthenia gravis, a chronic neuromuscular disease that causes weakness in the voluntary muscles. The application was based on the company's phase 3 Vivacity-MG3...
Copyright 2023-2026 - www.financetom.com All Rights Reserved